The SLS Europe team, alongside Serum Institute of India Pvt. Ltd., participated in the TBVI Symposium in Les Diablerets, contributing to discussions on the future of TB vaccine development. Our continued efforts with VPM1002 highlight our commitment to innovation in TB prevention.
Engaging with global experts fostered valuable exchanges on scientific advancements and strategic pathways for accelerating TB vaccine research. The symposium provided an excellent opportunity to strengthen collaborations and drive progress in the field.
A special thanks to TuBerculosis Vaccine Initiative (TBVI) for hosting this impactful event. Looking forward to the next discussions and future collaborations!